期刊论文详细信息
BMC Cancer
Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
Research Article
Hidetaka Yamamoto1  Yoshinao Oda1  Hirofumi Bekki1  Akira Maekawa1  Yuichi Yamada1  Kenichi Kohashi1  Michiyuki Hakozaki2  Kazuki Nabeshima3  Katsumi Harimaya4  Yukihide Iwamoto4 
[1] Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, 812-8582, Higashi-ku, Fukuoka, Japan;Department of Orthopaedic Surger, Fukushima Medical University School of Medicine, Fukushima, Japan;Department of Pathology, Graduate School of Medical Science, Fukuoka University, Fukuoka, Japan;Orthopaedic Surgery, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan;
关键词: Undifferentiated pleomorphic sarcoma;    Heat shock protein 90;    Akt/mammalian target of rapamycin pathway;    Mitogen-activated protein kinase pathway;    Phosphorylation;   
DOI  :  10.1186/s12885-015-1830-8
 received in 2015-07-22, accepted in 2015-10-16,  发布年份 2015
来源: Springer
PDF
【 摘 要 】

BackgroundUndifferentiated pleomorphic sarcoma (UPS) is a heterogeneous tumor group, and little is known about molecular target therapy for UPS. Heat shock protein 90 (HSP90) is an expressed chaperone that refolds certain denatured proteins under stress conditions. One of these proteins is Akt. The disruption of Akt signaling plays an important role in tumor progression. The present study’s purpose was to analyze the HSP90 expression, Akt/mTOR pathway activation and the correlation between HSP90 expression and its pathway activation in UPS.MethodsThe status of HSP90 and the profiles of the Akt/ mTOR pathway were assessed by immunohistochemistry in 79 samples of UPS, and these data were compared with clinicopathological and histopathological findings. The expressions of indicated proteins were assessed by Western blotting in five frozen samples. After treating UPS cells with the HSP90 inhibitor, we assessed the antitumor effect of the inhibitor.ResultsImmunohistochemically, phosphorylated Akt (p-Akt), p-mTOR, p-S6RP and p-4EBP were positive in 57.3, 51.9, 54.5 and 57.1 % of the UPS samples, respectively. The expressions of those phosphorylated proteins were correlated with each other. HSP90 expression was elevated in 56.4 % of the samples and was correlated with p-Akt, p-mTOR and p-S6RP. The immunohistochemical results were confirmed by Western blotting. The HSP90 inhibitor led to decreased viability and invasiveness of the cells and inactivated the AKT/mTOR pathway in vitro.ConclusionElevated expression of HSP90 is a poor-prognosis factor and is involved in the activation of the Akt/mTOR pathway in UPS. HSP90 inhibition is a potential treatment option for UPS.

【 授权许可】

CC BY   
© Bekki et al. 2015

【 预 览 】
附件列表
Files Size Format View
RO202311101577097ZK.pdf 1653KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  文献评价指标  
  下载次数:24次 浏览次数:0次